Skip to main content
OpenTrials

Clinical trial condition

Genital Diseases, Male

Explore clinical trials studying Genital Diseases, Male. Study availability and eligibility vary by location and protocol.

6,789 public trials 1,250 recruiting studies
Refine in advanced search Browse all conditions

Genital Diseases, Male trial results

Completed

Pemetrexed as Second-Line Therapy in Treating Patients With Hormone Refractory Prostate Cancer

NCT00216099

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Medical & Surgical Specialists, LLC Galesburg, Illinois, United States
  • Elkhart Clinic Elkhart, Indiana, United States
  • Fort Wayne Oncology & Hematology, Inc Fort Wayne, Indiana, United States
  • Indiana University Cancer Center Indianapolis, Indiana, United States
View all 15 locations
View Trial Details
Completed

Cabazitaxel and Abiraterone Acetate in Patients With Metastatic Castrate-Resistant Prostate Cancer

NCT01511536

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Investigational Site Number 840001 San Francisco, California, United States
  • Investigational Site Number 840002 New Haven, Connecticut, United States
  • Investigational Site Number 250001 Villejuif, France
  • Investigational Site Number 826001 Sutton, United Kingdom
View Trial Details
Completed

Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate Cancer

NCT00519285

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +11 more
Locations
  • Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States
  • Sanofi-Aventis Administrative Office Buenos Aires, Argentina
  • Sanofi-Aventis Administrative Office Macquarie Park, Australia
  • Sanofi-Aventis Administrative Office Diegem, Belgium
View all 31 locations
View Trial Details
Completed

A Clinical Trial to Study DR-2031 for the Treatment of Hot Flashes in Prostate Cancer Patients

NCT00196339

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +11 more
Locations
  • Duramed Investigational Site Birmingham, Alabama, United States
  • Duramed Investigational Site Birmingham, Alabama, United States
  • Duramed Investigational Site Homewood, Alabama, United States
  • Duramed Investigational Site Huntsville, Alabama, United States
View all 118 locations
View Trial Details
Completed

Soy Protein Supplement in Preventing Prostate Cancer in Patients With Elevated Prostate-Specific Antigen Levels

NCT00031746

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Walter Reed Army Medical Center Washington D.C., District of Columbia, United States
  • CCOP - Hematology-Oncology Associates of Central New York Syracuse, New York, United States
  • Community General Hospital of Greater Syracuse Syracuse, New York, United States
  • Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States
View Trial Details
Completed

Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer

NCT00006359

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Beebe Medical Center Lewes, Delaware, United States
  • CCOP - Christiana Care Health Services Newark, Delaware, United States
  • St. Francis Hospital Wilmington, Delaware, United States
  • Florida Hospital Cancer Institute at Florida Hospital Orlando Orlando, Florida, United States
View all 26 locations
View Trial Details
Completed

A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors

NCT01325558

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +55 more
Locations
  • Emory University, Winship Cancer Institute Atlanta, Georgia, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
  • University of Rochester Medical Center, James P. Wilmot Cancer Center Rochester, New York, United States
  • Carolinas Hematology-Oncology Associates Charlotte, North Carolina, United States
View Trial Details

Related conditions